Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial - Sanyal, A; Charles, E D; Neuschwander-Tetri, B A (Lancet, 2019)